Total Hip/Knee Replacement (THR/TKR) Manufacturer & Exporter in São Paulo

Executive Summary & Zynfuse Corporate Capabilities

Zynfuse Medical Technology Co., Ltd. stands as a pioneer in the global orthopedic device manufacturing sector. Specializing in advanced bone fusion and reconstructive implant systems, Zynfuse has consolidated its position by serving surgical innovators, hospital purchasing departments, and specialized orthopedic distributors worldwide. Established in 2016, the company leverages a robust legacy of 12 years of industry experience and 7 years of specialized medical device export history, ensuring that all logistics, quality checks, and product iterations conform to high-tier global expectations.

To maintain absolute batch-to-batch consistency required for Class III orthopedic implants, Zynfuse operates a state-of-the-art 18,600 m² manufacturing plant. The facility is governed by strict ISO 13485 quality systems and houses cleanrooms designed to control airborne particulates and bioburden. Backed by an annual export yield exceeding $18.5 million, Zynfuse operates an extensive supply chain with more than 1,200 international partners, ensuring that material procurement, precision milling, sterilization, and custom OEM/ODM packaging remain highly predictable and efficient.

Innovation at Zynfuse is driven by a specialized engineering department consisting of 85 dedicated R&D specialists. Through CAD modeling, finite element analysis (FEA), and clinical collaboration, the team creates over 320 new medical tools and implants annually. This high-capacity innovation pipeline allows Zynfuse to offer custom anatomical designs, modified sizing matrices, and OEM/ODM options to meet the strict clinical needs of healthcare networks in Brazil and broader Latin America.

Supply Chain Resilience & OEM/ODM Capacity

The global healthcare supply chain demands high efficiency and risk mitigation. Zynfuse addresses this through its advanced manufacturing hub, utilizing automated raw material logistics and modern production technology. The company sources high-purity raw materials, including medical-grade titanium alloys (Ti-6Al-4V ELI) conformant to ASTM F136 and Cobalt-Chromium-Molybdenum (CoCrMo) alloy conforming to ASTM F1537.

For orthopaedic distributors in São Paulo, Zynfuse utilizes optimized shipping lanes from China to Brazil, minimizing transport delays and ensuring consistent inventory levels for both planned surgeries and urgent trauma cases.

Technology Roadmap: Primary vs. Revision Systems

Zynfuse's joint reconstructive systems are engineered around key clinical goals: long-term implant survival, minimal wear debris, and stable primary fixation.

• Surface Texturing & Coating: Using automated vacuum plasma spraying (VPS) technology, Zynfuse applies dual-layer coatings consisting of micro-porous Titanium topped with crystalline Hydroxyapatite (HA). This structure mimics natural bone morphology, encouraging rapid osteoblast attachment and long-term biological fixation in cementless applications.
• Bearing Surface Innovation: Zynfuse utilizes high-purity medical ceramics (Biolox Delta type) coupled with Highly Cross-Linked Polyethylene (HXLPE) infused with Vitamin E. This combination reduces abrasive wear and helps prevent osteolysis, supporting the long-term survival of hip and knee replacements.
• Optimized Revision Options: Zynfuse’s revision systems feature modular femoral stems and adjustable tibial sleeves, allowing surgeons to address bone loss and structural instability with customizable fitting options.

Strict Quality Management & ANVISA Compliance

Under the oversight of 68 quality control specialists, Zynfuse executes a complete quality assurance workflow spanning every phase of manufacturing. All materials undergo initial chemical verification via optical emission spectrometers to confirm compliance with ASTM orthopedic standards.

Our quality testing protocol includes:

• Dimensional Verification: Using automated coordinate measuring machines (CMM) and video measuring systems, checking implant features against design models within micrometer tolerances.
• Mechanical Evaluation: Conducting static and dynamic fatigue tests (for example, femoral stem fatigue testing per ISO 7206) to evaluate long-term mechanical performance under physiological loads.
• Biocompatibility Assessments: Completing evaluations (including cytotoxicity, sensitization, and systemic toxicity testing per ISO 10993) to confirm the biological safety of implant surfaces.
• Cleanroom Monitoring: Performing scheduled particulate monitoring and bioburden testing within assembly areas to maintain clean packaging environments prior to sterilization.

To support Latin American distribution, Zynfuse provides comprehensive technical support and documentation packages. This includes detailed manufacturing flowcharts, raw material certifications, packaging validation reports, and sterilization summaries, helping to facilitate product registration and compliance with local regulatory requirements.